The mVT® Service is FDA Cleared to track disease progression in patients with Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). The mVT® App is prescribed to patients by their Optometrist, Ophthalmologist, or Retina Specialist. We monitor the patient's vision and alert the prescriber of any significant vision change.